Clinical outcome of ampicillin or ampicillin/sulbactam versus glycopeptides in ampicillin-susceptible Enterococcus faecalis/faecium bacteremia: a 10-year retrospective cohort study
Glycopeptide use was not associated with improved mortality in patients with ampicillin-susceptible E. faecalis/faecium bacteremia. This study provides insights to reduce the inappropriate use of glycopeptides in ampicillin-susceptible E. faecalis/faecium bacteremia treatment and promote antimicrobial stewardship.
Authors
- Yong Chan Kim (ORCID: https://orcid.org/0000-0001-5081-7906)
- Yeol Jung Seong (ORCID: https://orcid.org/0000-0002-6402-4082)
- Je Eun Song (ORCID: https://orcid.org/0000-0001-7056-6905)
- E. Lee
- Young Hwa Choi (ORCID: https://orcid.org/0000-0001-5254-3101)
- Jung Yeon Heo (ORCID: https://orcid.org/0000-0002-6548-1939)
- Eun Jin Kim (ORCID: https://orcid.org/0000-0001-7008-0497)
Institutions
- Duke University (US)
- Yonsei University (KR)
- Severance Hospital (KR)
- Inje University Ilsan Paik Hospital (KR)
- Busan Medical Center (KR)
- Ajou University (KR)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1186/s12879-024-09824-w
- Citations
- 4
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Yonsei University
- Yonsei University College of Medicine